Stay updated with breaking news from Michaela Dinerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 131,029 shares of the business’s stock in a transaction that occurred on Thursday, March 30th. The shares were sold at an average price of $17.00, for a total value of $2,227,493.00. Following the completion of the transaction, the chief financial officer now owns 147,778 […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 30,911 shares of the firm’s stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $18.00, for a total transaction of $556,398.00. Following the completion of the sale, the chief financial officer now owns 147,778 shares in […]
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective lifted by Truist Financial from $28.00 to $32.00 in a research report report published on Wednesday, The Fly reports. Truist Financial currently has a buy rating on the biotechnology company’s stock. Several other analysts have also issued reports on the company. HC Wainwright reiterated a […]
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective lifted by Raymond James from $12.00 to $35.00 in a research report released on Wednesday, The Fly reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also commented on VKTX. Stifel Nicolaus began […]
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price hoisted by Roth Mkm from $15.00 to $19.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the biotechnology company’s stock. Other equities research analysts also recently issued research reports about the stock. Oppenheimer lifted their price target […]